# Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

> **NCT03405064** · PHASE3 · COMPLETED · sponsor: **Wockhardt** · enrollment: 501 (actual)

## Conditions studied

- Acute Bacterial Skin and Skin Structure Infections

## Interventions

- **DRUG:** Oral Levonadifloxacin/Linezolid Tablet
- **DRUG:** Intravenous Levonadifloxacin/Linezolid Infusion

## Key facts

- **NCT ID:** NCT03405064
- **Lead sponsor:** Wockhardt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-25
- **Primary completion:** 2018-09-25
- **Final completion:** 2018-11-30
- **Target enrollment:** 501 (ACTUAL)
- **Last updated:** 2020-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03405064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03405064, "Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03405064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*